Therefore, in light of the present findings, we conclude that the overall metabolic impact of the absence of Malat1 on adipose tissue accretion and glucose intolerance is either physiologically not relevant upon aging and obesity, or that it is masked by as yet unknown compensatory mechanisms. The gene discussed is MALAT1; the disease is obesity disorder.